Sample 3 Treatment Agreement
Provides a sample consent for treatment with buprenorphine/naloxone.
For the patient’s admittance to the MAT program and initiation of medications to treat opioid use disorder.
Provides a sample consent for treatment with buprenorphine/naloxone.
Provides lessons learned from organizations with established MAT programs, including making the business case for MAT, securing buy-in from staff, overcoming community resistance, paying for MAT, finding prescribers, obtaining licenses and credentials, screening and assessing patients, combining medication and therapy, and sustaining a MAT program.
Contains resources for addiction medicine professionals to create comprehensive and individualized treatment plans.